BIA welcomes investment by the Government into lipid supply chain at Croda

Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) and former member of the Vaccine taskforce (2020) said: “The UK has been at the forefront of the global response to the COVID-19 pandemic, developing and manufacturing vaccines required to end global lockdowns. The acceleration of mRNA technology has been astonishing during the pandemic and it is now set to be a significant industrial opportunity. The Government's investment will increase a vital part of the mRNA supply chain here in the UK and will lead to an expansion at the Croda facility, creating jobs and investment in the Staffordshire area.

“This investment will support those made by the UK Vaccine Taskforce’s into CPI’s mRNA training centre and the creation of the Cell and Gene Manufacturing Innovation Centre in Braintree which will have the capability to manufacture mRNA vaccines and therapies. Coupled with significant private sector investments into UK mRNA manufacturing as well as the UK’s strength in academic understanding of mRNA, means the UK life sciences and biotech sector is well poised to be a global leader in this innovative area in the years to come.”